India Partnering Award: Exploiting the microbial diversity of the Sundarbans mangrove delta to tackle infectious disease
Lead Research Organisation:
University of Birmingham
Department Name: Sch of Biosciences
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
People |
ORCID iD |
| Apoorva Bhatt (Principal Investigator) | |
| Robin May (Co-Investigator) |
| Description | The project studies isolatesfrom the Sundarbans delta in India, that produce antimicrobials. The award has allowed exchange of research staff, and a visiting postdoctoral scientist from Calcutta was able to visit Birmingham to isolate an active component from this strain that not only shows anti-mycobnacterial acitivity (agaisnt the tuberculosis causing pathogen), but also anti-fungal activity against a pathogenic fungus, Cryptococcus. |
| Exploitation Route | Our research is in progress and it is too early to comment. |
| Sectors | Pharmaceuticals and Medical Biotechnology |
| Title | Draft Genome Sequence of Bioactive Strain Streptomyces sp. SMS_SU21, Isolated from Soil Sediment of the Sundarbans Mangrove Ecosystem |
| Description | Draft Genome Sequence of Bioactive Strain Streptomyces sp. SMS_SU21, Isolated from Soil Sediment of the Sundarbans Mangrove Ecosystem |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | The genome sequence has advanced our understanding of the potential of this strain to produce antimicrobials and now allows us to probe individual clusters to identify the anti bacterial and anti fungal produced by this actinomycete. |